The Administrative Core of the Duke Autoimmunity Center of Excellence (ACE) will provide leadership and support for the two basic research projects, the Pilot Research Project (if approved), the 5 ongoing clinical trials, and any new clinical trials approved by ACE Steering Committee. Its overarching goal will be to promote the objectives of this integrated basic and clinical research program, ensure the quality and progress of the individual funded projects, foster interactions among basic and clinical scientists, and facilitate the appropriate dissemination of research findings. The core will be under the direction of Dr. E. William St.Clair (Principal Investigator) who will also serve as the Clinical Research Representative. He will be responsible for overseeing all budgetary matters of the Duke ACE, organizing monthly meetings of the Executive Committee, arranging for the twice yearly ACE research meetings, and coordinating the preparation of non-competitive renewal applications. Dr. Tedder will serve as the Associate Director and Basic Research Representative of the Administrative Core and work closely with Dr. St.Clair in managing the ACE research enterprise, ensuring program relevance, and facilitating interactions between the basic and clinical scientists. Tammy Caudil (Department of Immunology) and Patty Might Davis (Division of Rheumatology and Immunology) will provide administrative support for the core. Together, they will adminstrate the fmaces, coordinate meetings, interface with NIAID staff and the institution responsible for the management of the ACE Discretionary Fund. The core will also utilize an Executive Committee to ensure effective management and integration of the projects, as well as coordinate an annual review of the resarch activities by the Duke ACE Advisory Board. Drs. St.Clair and Tedder will be joined on the Executive committee by Drs. Garnett Kelsoe, Russell Hall, and David Pisetsky. The Core will also support educational activities to enhance the visibility of the Center within Duke and provide a forum for communicating and exchanging research ideas. The Administrative Core will nurture a vibrant, interactive program of clinical and basic research that will advance our understanding about the role of B cells in autoimmune disease.

Public Health Relevance

The Administrative Core of the will support the basic and clinical research activities of the Duke Autoimmunity Center of Excellence and be led by Dr. E. William St.Clair (Director, Clinical Research Representative) and Dr. Thomas F. Tedder (Associate Director, Basic Research Representative). It will oversee all budgetary aspects of the Duke ACE and ensure the quality and progress of the projects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI056363-10
Application #
8466198
Study Section
Special Emphasis Panel (ZAI1-QV-I)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
10
Fiscal Year
2013
Total Cost
$121,206
Indirect Cost
$32,091
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
St Clair, E William; Baer, Alan N; Wei, Chungwen et al. (2018) Clinical Efficacy and Safety of Baminercept, a Lymphotoxin ? Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol 70:1470-1480
Cornec, Divi; Kabat, Brian F; Mills, John R et al. (2018) Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis. Rheumatology (Oxford) 57:639-650
Haddon, D James; Wand, Hannah E; Jarrell, Justin A et al. (2017) Proteomic Analysis of Sera from Individuals with Diffuse Cutaneous Systemic Sclerosis Reveals a Multianalyte Signature Associated with Clinical Improvement during Imatinib Mesylate Treatment. J Rheumatol 44:631-638
Ponnuswamy, Padmapriya; Joffre, Jeremie; Herbin, Olivier et al. (2017) Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells. Sci Rep 7:4111
Su, Kuei-Ying; Watanabe, Akiko; Yeh, Chen-Hao et al. (2016) Efficient Culture of Human Naive and Memory B Cells for Use as APCs. J Immunol 197:4163-4176
Cao, Yonghao; Amezquita, Robert A; Kleinstein, Steven H et al. (2016) Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-?, and GM-CSF and Diminished IL-10 Production. J Immunol 196:2075-84
Cui, Ang; Di Niro, Roberto; Vander Heiden, Jason A et al. (2016) A Model of Somatic Hypermutation Targeting in Mice Based on High-Throughput Ig Sequencing Data. J Immunol 197:3566-3574
Meckel, Katherine; Li, Yan Chun; Lim, John et al. (2016) Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis. Am J Clin Nutr 104:113-20
Londin, Eric; Loher, Phillipe; Telonis, Aristeidis G et al. (2015) Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc Natl Acad Sci U S A 112:E1106-15
McHugh, Michael D; Park, Jason; Uhrich, Ross et al. (2015) Paracrine co-delivery of TGF-? and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells. Biomaterials 59:172-81

Showing the most recent 10 out of 144 publications